20651-72-3

Basic information

• Product Name: 3-butylbenzoic acid
• CAS NO: 20651-72-3
• Molecular Formula: C₁₁H₁₄O₂
• Molecular Weight: 178.2277
• Mol File: 20651-72-3.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 307.3°C at 760 mmHg
• Flash Point: 144.4°C
• Density: 1.062g/cm³
• Vapor Pressure: 0.000318mmHg at 25°C
• Refractive Index: 1.532
• CAS DataBase Reference: 3-butylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-butylbenzoic acid(20651-72-3)
• EPA Substance Registry System: 3-butylbenzoic acid(20651-72-3)

Safety Data

• Hazardous Substances Data: 20651-72-3(Hazardous Substances Data)

Usage

General Description

3-butylbenzoic acid is a chemical compound with the molecular formula C11H14O2. It is a carboxylic acid that is derived from benzoic acid with a butyl group attached to the benzene ring. 3-butylbenzoic acid is commonly used in the production of various industrial products, including fragrances, dyes, and pharmaceuticals. It has also been studied for its potential antimicrobial, anti-inflammatory, and antioxidant properties. 3-butylbenzoic acid is known for its ability to inhibit the growth of certain bacteria and fungi, making it a valuable ingredient in the development of antimicrobial agents. 3-butylbenzoic acid is also used in the synthesis of liquid crystals and as a starting material for the production of other organic compounds.

Upstream product

• 124-38-9 carbon dioxide 
• 54887-20-6 1-bromo-3-n-butylbenzene 
• 104-13-2 4-Butylaniline 
• 51605-98-2 2-bromo-4-butylaniline 
• 20651-70-1 methyl 3-butylbenzoate 

Downstream Products

• 54887-21-7 m-butylbenzoyl chloride 
• 54887-22-8 3-Butyl-benzoic acid 2-diethylamino-ethyl ester 
• 1313217-90-1 [(3-perfluorobutyl)phenyl]methanol 

Relevant articles and documents

Demonstrating Ligandability of the LC3A and LC3B Adapter Interface

Autophagy is the common name for a number of lysosome-based degradation pathways of cytosolic cargos. The key components of autophagy are members of Atg8 family proteins involved in almost all steps of the process, from autophagosome formation to their selective fusion with lysosomes. In this study, we show that the homologous members of the human Atg8 family proteins, LC3A and LC3B, are druggable by a small molecule inhibitor novobiocin. Structure-activity relationship (SAR) studies of the 4-hydroxy coumarin core scaffold were performed, supported by a crystal structure of the LC3A dihydronovobiocin complex. The study reports the first nonpeptide inhibitors for these protein interaction targets and will lay the foundation for the development of more potent chemical probes for the Atg8 protein family which may also find applications for the development of autophagy-mediated degraders (AUTACs).